1
|
Zhuo Y, Huang X, Lin NL, Yu FQ, Chen YX, Guan MH, Yi WQ, Lai FC. SiO 2/hyaluronic acid nanoparticles carry CaO 2, DOX and p53 plasmid to effectively achieve ion interference/chemical/gene multimodal therapy of lung cancer. Biomater Sci 2023. [PMID: 37140070 DOI: 10.1039/d2bm02075k] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 05/05/2023]
Abstract
Monotherapy of lung cancer shows limited therapeutic effects due to its poorly targeted enrichment and low bioavailability. Using nanomaterials as carriers to form drug delivery systems has become a popular method to improve the targeting of anticancer drug therapy and patients' safety. However, the uniformity of the loaded drugs and the unsatisfactory effects are still the bottleneck in this field up to now. This study aims to construct a novel nanocomposite carrying 3 different types of anticancer drugs to enhance treatment efficacy. Herein, mesoporous silica (MSN) with high loading rate was constructed by dilute sulfuric acid thermal etching as the framework. Hyaluronic acid (HA) was loaded with CaO2, p53 and DOX to construct nanoparticle complexes-SiO2@CaO2@DOX@P53-HA. First, MSN was proved to be a porous sorbent with a mesoporous structure through BET analysis. The images obtained from the uptake experiment clearly show the gradual enrichment of the DOX and Ca2+ within the target cell. For in vitro experiments, the pro-apoptotic effects of SiO2@CaO2@DOX@P53-HA significantly increased compared to that of the single-agent group at different time points. Furthermore, in the tumor-bearing mouse experiment, the tumor volume was remarkably inhibited in the SiO2@CaO2@DOX@P53-HA group compared to that in the single-agent group. By observing the pathological sections of the euthanized mice, it is obvious that the tissues of the mice treated with the nanoparticles were more intact. Based on these beneficial results, it is believed that multimodal therapy is a meaningful treatment strategy for lung cancer.
Collapse
Affiliation(s)
- Yi Zhuo
- Department of Thoracic Surgery, the First Affiliated Hospital, Fujian Medical University, Fuzhou 350005, China.
- Department of Thoracic Surgery, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou 350212, China
| | - Xuan Huang
- Department of Thoracic Surgery, the First Affiliated Hospital, Fujian Medical University, Fuzhou 350005, China.
- Department of Thoracic Surgery, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou 350212, China
| | - Nan-Long Lin
- Department of Thoracic Surgery, the First Affiliated Hospital, Fujian Medical University, Fuzhou 350005, China.
- Department of Thoracic Surgery, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou 350212, China
| | - Feng-Qiang Yu
- Department of Thoracic Surgery, the First Affiliated Hospital, Fujian Medical University, Fuzhou 350005, China.
- Department of Thoracic Surgery, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou 350212, China
| | - Yan-Xun Chen
- Department of Thoracic Surgery, the First Affiliated Hospital, Fujian Medical University, Fuzhou 350005, China.
- Department of Thoracic Surgery, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou 350212, China
- Department of Thoracic Surgery, Quangang District Hospital, Quanzhou 362100, China
| | - Mao-Hao Guan
- Department of Thoracic Surgery, the First Affiliated Hospital, Fujian Medical University, Fuzhou 350005, China.
- Department of Thoracic Surgery, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou 350212, China
| | - Wei-Qiang Yi
- Department of Thoracic Surgery, the First Affiliated Hospital, Fujian Medical University, Fuzhou 350005, China.
- Department of Thoracic Surgery, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou 350212, China
| | - Fan-Cai Lai
- Department of Thoracic Surgery, the First Affiliated Hospital, Fujian Medical University, Fuzhou 350005, China.
- Department of Thoracic Surgery, National Regional Medical Center, Binhai Campus of the First Affiliated Hospital, Fujian Medical University, Fuzhou 350212, China
| |
Collapse
|
2
|
Naszályi Nagy L, Dhaene E, Van Zele M, Mihály J, Klébert S, Varga Z, Kövér KE, De Buysser K, Van Driessche I, Martins JC, Fehér K. Silica@zirconia Core@shell Nanoparticles for Nucleic Acid Building Block Sorption. NANOMATERIALS (BASEL, SWITZERLAND) 2021; 11:2166. [PMID: 34578482 PMCID: PMC8468278 DOI: 10.3390/nano11092166] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Download PDF] [Figures] [Subscribe] [Scholar Register] [Received: 07/01/2021] [Revised: 08/02/2021] [Accepted: 08/13/2021] [Indexed: 12/27/2022]
Abstract
The development of delivery systems for the immobilization of nucleic acid cargo molecules is of prime importance due to the need for safe administration of DNA or RNA type of antigens and adjuvants in vaccines. Nanoparticles (NP) in the size range of 20-200 nm have attractive properties as vaccine carriers because they achieve passive targeting of immune cells and can enhance the immune response of a weakly immunogenic antigen via their size. We prepared high capacity 50 nm diameter silica@zirconia NPs with monoclinic/cubic zirconia shell by a green, cheap and up-scalable sol-gel method. We studied the behavior of the particles upon water dialysis and found that the ageing of the zirconia shell is a major determinant of the colloidal stability after transfer into the water due to physisorption of the zirconia starting material on the surface. We determined the optimum conditions for adsorption of DNA building blocks, deoxynucleoside monophosphates (dNMP), the colloidal stability of the resulting NPs and its time dependence. The ligand adsorption was favored by acidic pH, while colloidal stability required neutral-alkaline pH; thus, the optimal pH for the preparation of nucleic acid-modified particles is between 7.0-7.5. The developed silica@zirconia NPs bind as high as 207 mg dNMPs on 1 g of nanocarrier at neutral-physiological pH while maintaining good colloidal stability. We studied the influence of biological buffers and found that while phosphate buffers decrease the loading dramatically, other commonly used buffers, such as HEPES, are compatible with the nanoplatform. We propose the prepared silica@zirconia NPs as promising carriers for nucleic acid-type drug cargos.
Collapse
Affiliation(s)
- Livia Naszályi Nagy
- NMR and Structure Analysis Research Group, Department of Organic and Macromolecular Chemistry, Ghent University, Krijgslaan 281 S4, B-9000 Ghent, Belgium; (L.N.N.); (J.C.M.)
| | - Evert Dhaene
- Sol-Gel Centre for Research on Inorganic Powders and Thin Films Synthesis, Department of Chemistry, Ghent University, Krijgslaan 281 S3, B-9000 Ghent, Belgium; (E.D.); (M.V.Z.); (K.D.B.); (I.V.D.)
| | - Matthias Van Zele
- Sol-Gel Centre for Research on Inorganic Powders and Thin Films Synthesis, Department of Chemistry, Ghent University, Krijgslaan 281 S3, B-9000 Ghent, Belgium; (E.D.); (M.V.Z.); (K.D.B.); (I.V.D.)
| | - Judith Mihály
- Institute of Materials and Environmental Chemistry, Research Centre for Natural Sciences, Eötvös Loránd Research Network (IMEC RCNS ELKH), Magyar Tudósok Körútja 2, H-1117 Budapest, Hungary; (J.M.); (S.K.); (Z.V.)
| | - Szilvia Klébert
- Institute of Materials and Environmental Chemistry, Research Centre for Natural Sciences, Eötvös Loránd Research Network (IMEC RCNS ELKH), Magyar Tudósok Körútja 2, H-1117 Budapest, Hungary; (J.M.); (S.K.); (Z.V.)
| | - Zoltán Varga
- Institute of Materials and Environmental Chemistry, Research Centre for Natural Sciences, Eötvös Loránd Research Network (IMEC RCNS ELKH), Magyar Tudósok Körútja 2, H-1117 Budapest, Hungary; (J.M.); (S.K.); (Z.V.)
| | - Katalin E. Kövér
- Department of Inorganic and Analytical Chemistry, University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary;
| | - Klaartje De Buysser
- Sol-Gel Centre for Research on Inorganic Powders and Thin Films Synthesis, Department of Chemistry, Ghent University, Krijgslaan 281 S3, B-9000 Ghent, Belgium; (E.D.); (M.V.Z.); (K.D.B.); (I.V.D.)
| | - Isabel Van Driessche
- Sol-Gel Centre for Research on Inorganic Powders and Thin Films Synthesis, Department of Chemistry, Ghent University, Krijgslaan 281 S3, B-9000 Ghent, Belgium; (E.D.); (M.V.Z.); (K.D.B.); (I.V.D.)
| | - José C. Martins
- NMR and Structure Analysis Research Group, Department of Organic and Macromolecular Chemistry, Ghent University, Krijgslaan 281 S4, B-9000 Ghent, Belgium; (L.N.N.); (J.C.M.)
| | - Krisztina Fehér
- Molecular Recognition and Interaction Research Group, Hungarian Academy of Sciences-Eötvös Loránd Research Network at University of Debrecen, Egyetem tér 1, H-4032 Debrecen, Hungary
| |
Collapse
|